Elekta sues ZAP Surgical Systems, claiming patent infringement
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Rad Oncology Homepage

MD Anderson to expand proton therapy center with $159 million project Increases accessibility to higher number of patients

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

New technique may concentrate radiotherapy dose for minimal tissue damage Utilizes very high energy electrons (VHEEs)

MedAustron delivers first bout of carbon ion therapy on patient Sixth center in the world to offer treatment

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Elekta is suing ZAP Surgical
Systems over what it claims is
patent infringement of its rotatable
radiation treatment system

Elekta sues ZAP Surgical Systems, claiming patent infringement

by John R. Fischer , Staff Reporter
Radiotherapy provider Elekta is taking ZAP Surgical Systems to court over allegations of patent infringement, regarding the design of a radiosurgery platform.

The California-based enterprise filed the suit, titled Elekta Limited and Elekta Inc. v. ZAP Surgical Systems, Inc., this month in the United States District Court for the Northern District of California, asserting that the manufacturing, importation, advertising, sale and use of the ZAP-X Gyroscopic Radiosurgery Platforms violates a patent for a rotatable treatment system designed by Elekta.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

"Zap Surgical is acting quickly and will defend itself aggressively," said John Adler in a statement to HCB News. "We have engaged with legal counsel and already our team has identified several promising non-infringement and invalidity positions that we are working to develop further."

Elekta Limited is seeking monetary damages with a threefold enhancement for willful infringement, and an injunction to prevent the importing, manufacturing, sale and use of the product in the U.S.

"Elekta is a recognized innovator in radiation-based treatment technologies," said Jonas Bolander, general counsel and executive vice president for Elekta, in a statement. "We invest heavily in the research and development of new and better therapies for patients, and we value and vigorously protect the intellectual property rights that result from such investment. As demonstrated in the past, Elekta will not accept any violation of its intellectual property rights."

Its suit follows the adoption of ZAP Surgical Systems’ radiosurgery platform, which gained FDA clearance in 2017, by Barrow Brain and Spine in Phoenix, Arizona to deliver stereotactic radiotherapy to treat patients with brain tumors. In addition, clinical trials are expected to begin in June in Beijing.

Equipped with self-shielding technology, the solution is designed as an alternative to invasive surgery that delivers high-dose radiation to brain tumors precisely, while protecting normal brain tissue and other organs, such as the eyes. It requires no cement radiation vault to protect operators when in use, saving providers an estimated one to two million dollars.

“It’s like a shaper knife,” Dr. John Adler, founder and CEO of ZAP Surgical Systems and a professor of Neurosurgery at Stanford University, told HCB News at the time of its adoption at Barrow Brain and Spine, noting that the ZAP-X platform is more precise, from more directions, than existing SRS technology. The ZAP-X is also safer because it lets operators record the radiation as it is being administered, he added.

The patent, No. 7,295,648, is one of many granted worldwide and claims priority from GB Patent Application Nos. 0324676.6 and 0325698.9.

Elekta did not respond for comment.

Rad Oncology Homepage

You Must Be Logged In To Post A Comment